The cytotoxic effects of autoantibodies to DFS70/LEDGF and the extracellular release of this protein, if confirmed in other contexts, could be exploited for therapeutic interventions in diseases where this protein plays a pathological role, such as HIV/AIDS and cancer. The gene discussed is PSIP1; the disease is cancer.